Skip to main content

Advertisement

SpringerLink
Log in

Ocular vasculitis

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Systemic vasculitis can affect practically any structure in or around the eye. Although the ocular presentations of vasculitic disease are highly variable and may be quite subtle, it is important for physicians to understand some of the basic concepts, critical findings, and potential significance of ocular signs and symptoms. In addition to preserving sight, awareness of specific ocular syndromes may afford a critical clue to undiagnosed or newly active systemic vasculitis. A brief discussion of the most common ocular syndromes seen in systemic vascular disease is presented, with special attention given to the signs that may be appreciated by non-ophthalmologists. Recent concepts of ocular immunologic therapy are also reviewed, especially as they relate to the use of systemic immunomodulating drugs, because care of these patients often requires close cooperation between ophthalmologists, primary care physicians, and rheumatologists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener’s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983, 98:76.

    CAS  PubMed  Google Scholar 

  2. Afshari NA., Afshari MA, Foster CS: Inflammatory conditions of the eye associated with rheumatic diseases. Curr Rheumatol Rep 2001, 3:453–458. A well-written recent review of connective tissue and vasculitic syndromes resulting in ocular inflammatory conditions.

    Article  CAS  PubMed  Google Scholar 

  3. Jabs DA, Rosenbaum JT, Foster CS, et al.: Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000, 130:492–513. A major review of the use of steroids and immunosuppressive drugs in the management of ocular inflammation centering on evidencebased data regarding the efficacy and safety of the foremost agents.

    Article  CAS  PubMed  Google Scholar 

  4. Bloch-Michel E, Nussenblatt R: International uveitis study group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 1987, 103:234–235.

    CAS  PubMed  Google Scholar 

  5. Waheed NK, Miserocchi E, Foster CS: Ocular concerns in juvenile rheumatoid arthritis. Int Ophthalmol Clin 2001, 41:223–234.

    Article  CAS  PubMed  Google Scholar 

  6. Nussenblatt RB: Uveitis in Behçet’s disease. Int Rev Immunol 1997, 14:67–79.

    CAS  PubMed  Google Scholar 

  7. Dodds EM: Treatment strategies in patients with anterior uveitis. Int Ophthalmol Clin 2000, 40:55–68.

    Article  CAS  PubMed  Google Scholar 

  8. Caprioli J, Samson CM, Foster CS, et al.: Uveitis and glaucoma. J Glaucoma 2000, 9:463–467.

    CAS  PubMed  Google Scholar 

  9. George RK, Chan C, Whitcup SM, Nussenblatt RB: Ocular immunopathology of Behçet’s disease. Surv Ophthalmol 1997, 42:157–162.

    Article  CAS  PubMed  Google Scholar 

  10. Nguyen QD, Uy HS, Akpek EK, et al.: Choroidopathy of systemic lupus erythematosus. Lupus 2000, 9:288–298.

    Article  CAS  PubMed  Google Scholar 

  11. Rojas B, Zafirakis P, Christen W, et al.: Medical treatment of macular edema in patients with uveitis. Doc Ophthalmol 1999, 97:399–407.

    Article  CAS  PubMed  Google Scholar 

  12. Lightman S: New therapeutic options in uveitis. Eye 1997, 11:222–226.

    PubMed  Google Scholar 

  13. Sabrosa NA, Pavesio C: Treatment strategies in patients with posterior uveitis. Int Ophthalmol Clin 2000, 40:153–161. Presents data and recommendations regarding recent advances in the treatment of posterior uveitis, including local and systemic therapeutic options.

    Article  CAS  PubMed  Google Scholar 

  14. Lightman S: Use of steroids and immunosuppressive drugs in the management of posterior uveitis. Eye 1991, 5:294–298.

    PubMed  Google Scholar 

  15. Samson CM, Waheed N, Baltatzis S, Foster CS: Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology 2001, 108:1134–1139. This study found methotrexate to be a safe and effective adjunctive treatment in patients with chronic or refractory uveitis.

    Article  CAS  PubMed  Google Scholar 

  16. Solomon SD, Cunningham ET: Use of corticosteroids and noncorticosteroid immunosuppressive agents in patients with uveitis. Compr Opthalmol Update 2000, 1:273–286. A recent review of the immunopathology of uveitis and the rationale for the use of immunomodulating agents for uveitic syndromes.

    Google Scholar 

  17. Akpek EK, Uy HS, Christen W, et al.: Severity of episcleritis and systemic disease association. Ophthalmology 1999, 106:729–731. A retrospective study that finds a meaningful correlation between the type and severity of episcleritis with the frequency of systemic diseases.

    Article  CAS  PubMed  Google Scholar 

  18. Pavesio CE, Meier FM: Systemic disorders associated with episcleritis and scleritis. Opinion Ophthalmol 2001, 12:471–478. A review of systemic syndromes that may present initially or consequently as ocular surface inflammation, and guidelines for systemic work-up in these conditions.

    Article  CAS  Google Scholar 

  19. Akpek EK, Foster CS: Primary intraocular lymphoma with a low interleukin 10 to interleukin 6 ratio and heterogeneous IgH gene arrangement. Arch Ophthalmol 2000, 118:731–732.

    CAS  Google Scholar 

  20. White GE: Episcleritis and scleritis. Optom Clin 1991, 1:79–87.

    CAS  PubMed  Google Scholar 

  21. Fong LP, Sainz de la Maza M, Rice BA, et al.: Immunopathology of scleritis. Ophthalmology 1991, 98:472–479.

    CAS  PubMed  Google Scholar 

  22. Pavesio CE, Meier FM: Systemic disorders associated with episcleritis and scleritis. Curr Opin Ophthalmol 2001, 12:471–478.

    Article  CAS  PubMed  Google Scholar 

  23. Watson PG, Heyreh SS: Episcleritis and scleritis. Br J Ophthalmol 1976, 60:163–191.

    CAS  PubMed  Google Scholar 

  24. Sainz de la Maza M, Jabbur NS, Foster CS: Severity of scleritis and episcleritis. Ophthalmology 1994, 101:389–396.

    CAS  PubMed  Google Scholar 

  25. Legmann A, Foster CS: Noninfectious necrotizing scleritis. Int Ophthalmol Clin 1996, 36:73–80.

    Article  CAS  PubMed  Google Scholar 

  26. Foster CS, Sainz de la Maza M: Sclera. New York: Springer-Verlag; 1994:95–136.

    Google Scholar 

  27. Sainz de la Maza M, Foster CS, Jabbur NS: Scleritis associated with systemic vasculitic diseases. Ophthalmology 1995, 102:687–692.

    CAS  PubMed  Google Scholar 

  28. McCluskey PJ, Wakefield D, Penny R: Scleritis and the spectrum of external inflammatory eye disease. Aust N Z J Ophthalmol 1985, 13:159–164.

    CAS  PubMed  Google Scholar 

  29. Sainz de la Maza M, Foster CS, Jabbur NS, Baltatzis S: Ocular characteristics and disease associations in scleritis-associated peripheral keratopathy. Arch Ophthalmol 2002, 120:15–19.

    PubMed  Google Scholar 

  30. Miserocchi E, Baltatzis S, Foster CS: A case of atypical Cogan’s syndrome with uncommon corneal findings. Cornea 2001, 20:540–542.

    Article  CAS  PubMed  Google Scholar 

  31. Ekong T: Peripheral ulcerative keratitis. http://www.uveitis.org/Enhanced/MD_info/md_puk.htm. Accessed July 18, 2002.

  32. Messmer EM, Foster CS: Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 1999, 43:379–396. A thorough and important review of ulcerative keratitis, its diagnosis, treatment, and association with systemic vasculitis.

    Article  CAS  PubMed  Google Scholar 

  33. Ladas JG, Mondino BJ: Systemic disorders associated with peripheral corneal ulceration. Curr Opinion Ophthalmol 2000, 11:468–471.

    Article  CAS  Google Scholar 

  34. Jifi-Bahlool H, Saadeh C, O’Connor J: Peripheral ulcerative keratitis in the setting of rheumatoid arthritis: treatment with immunosuppressive therapy. Semin Arthritis Rheum 1995, 25:67–73.

    Article  CAS  PubMed  Google Scholar 

  35. Sainz de la Maza M, Foster CS: The diagnosis and treatment of peripheral ulcerative keratitis. Semin Ophthamol 1991, 3:133.

    Google Scholar 

  36. Messmer EM, Foster CS: Destructive corneal and scleral disease associated with rheumatoid arthritis: medical and surgical management. Cornea 1995, 14:408–417.

    Article  CAS  PubMed  Google Scholar 

  37. Foster CS, Forstot SL, Wilson LA: Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis: effects of systemic immunosuppression. Ophthalmology 1984, 91:1253–1263.

    CAS  PubMed  Google Scholar 

  38. Kopstein AB, Kristopaitis T, Gujrati TM, et al.: Orbital Wegener granulomatosis without systemic findings. Ophthal Plast Reconstr Surg 1999, 15:467–469.

    Article  CAS  PubMed  Google Scholar 

  39. Soheilian M, Bagheri A, Aletaha M: Dacryoadenitis as the earliest presenting manifestation of systemic Wegener’s granulomatosis. Eur J Ophthalmol 2002, 12:241–243.

    CAS  PubMed  Google Scholar 

  40. Takanashi T, Uchida S, Arita M, et al.: Orbital inflammatory pseudotumor and ischemic vasculitis in Churg-Strauss syndrome: report of two cases and review of the literature. Ophthalmology 2001, 108:1129–1133.

    Article  CAS  PubMed  Google Scholar 

  41. Stavrou P, Murray PI, Batta K, Gordon C: Acute ocular ischemia and orbital inflammation associated with systemic lupus erythematosus. Br J Ophthalmol 2002, 86:474–475.

    Article  CAS  PubMed  Google Scholar 

  42. Lee AG, Tang RA, Feldon SE, et al.: Orbital presentations of giant cell arteritis. Graefes Arch Clin Exp Ophthalmol 2001, 239:509–513.

    Article  CAS  PubMed  Google Scholar 

  43. Hayreh SS: Anterior ischemic optic neuropathy. Neuroscience 1997, 4:251–263.

    CAS  Google Scholar 

  44. Arnold AC: Ischemic optic neuropathies. Ophthalmol Clin North Am 2001, 14:83–98.

    CAS  PubMed  Google Scholar 

  45. Gurwood AS, Malloy KA: Giant cell arteritis. Clin Exp Optometry 2002, 85:19–26.

    Article  Google Scholar 

  46. Borruat FX: Neuro-ophthalmologic manifestations of rheumatologic and associated disorders. Curr Opin Ophthalmol 1996, 7:10–18.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Washington University in St. Louis School of Medicine, 660 South Euclid Avenue, Campus Box 8096, 63130, St. Louis, MO, USA

    J. Banks Shepherd III MD

Authors
  1. J. Banks Shepherd III MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shepherd, J.B. Ocular vasculitis. Curr Rheumatol Rep 5, 100–106 (2003). https://doi.org/10.1007/s11926-003-0037-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-003-0037-1

Keywords

Search

Navigation